EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FAIRly deferred: Low impact of the individualised risk assessment policy on blood donor deferrals in England

Katherine Daly iD, Claire Reynolds iD, Katy Davison iD, Susan R Brailsford iD

Transfusion Medicine · 17.06.2026

DOI: 10.1111/tme.70091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion Medicine, online erschienen am 17.06.2026. Verfasst von Katherine Daly und 3 weiteren Autor:innen. Beteiligte Einrichtung: NHS Blood and Transplant/UK Health Security Agency Epidemiology Unit, UK Health Security Agency, London, UK. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess the impact of the individualised risk‐based donor selection guidelines on deferral of blood donors at donation sessions in England.

Background

From June 2021, the 3‐month deferral for sex between men was replaced by an individualised risk assessment known as FAIR (For the Assessment of Individualised Risk). Assessing the impact of deferral at donation informs donor and policy management.

Methods

Data were obtained from the NHS Blood and Transplant donor management system for deferrals associated with FAIR deferral codes or injecting drug use after FAIR implementation, 14 June 2021 to 13 June 2023. Rates for each deferral category were estimated by age group, sex, ethnic group, and donor type. Pre‐donation forms were reviewed for evidence of multiple deferrable behaviours, and return rates were calculated for temporarily deferred donors.

Results

Over 2 years, 286 donors were deferred on‐session due to FAIR (9.0 donors per 100 000 donations made). Highest adjusted incidence rate ratios of deferral were seen in first‐time, male, 17‐ to 24‐year‐old, and Mixed and Other ethnicity donors. Multiple FAIR deferrals were observed in 10 donors. Of 220 temporarily deferred donors, 56.8% returned to donate within 6 months.

Conclusion

The impact of FAIR on donation session appears low, supported by good return rates. First‐time, male, and younger donors were most affected. Multiple FAIR deferrals in a donor were rare, suggesting donors at higher risk were not attending to donate. Clarity on deferral application may aid donors and staff to defer appropriately. Further investigation is needed to determine levels of ineligible donation.

Schlagwörter

Stichwörter der Autor:innen

blood donationblood donorsdeferralinfectionsafety

Autor:innen und Institutionen

  • NHS Blood and Transplant/UK Health Security Agency Epidemiology Unit, UK Health Security Agency, London, UK.
  • NHS Blood and Transplant/UK Health Security Agency Epidemiology Unit, NHS Blood and Transplant, London, UK.
  • Microbiology Services, NHS Blood and Transplant, London, UK.

ORCID-Profile: Katherine Daly, Claire Reynolds, Katy Davison, Susan R Brailsford

Zitieren

APA

Daly, K., Reynolds, C., Davison, K., & Brailsford, S. R. (2026). FAIRly deferred: Low impact of the individualised risk assessment policy on blood donor deferrals in England. Transfusion Medicine. https://doi.org/10.1111/tme.70091

Vancouver

Daly K, Reynolds C, Davison K, Brailsford SR. FAIRly deferred: Low impact of the individualised risk assessment policy on blood donor deferrals in England. Transfusion Medicine. 2026. doi:10.1111/tme.70091

BibTeX
@article{Daly2026,
  author = {Daly, Katherine and Reynolds, Claire and Davison, Katy and Brailsford, Susan R},
  title = {FAIRly deferred: Low impact of the individualised risk assessment policy on blood donor deferrals in England},
  journal = {Transfusion Medicine},
  year = {2026},
  doi = {10.1111/tme.70091}
}
Kostenlos starten →